Chemotherapy Combined With Bevacizumab Neoadjuvant Therapy for HER2-negative Breast Cancer

NCT05525767 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: Bevacizumab

Sponsor

Hebei Medical University Fourth Hospital